Catalysts for Kadcyla
14 tracked
Mar 26, 2026
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
May 14, 2025
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Feb 2, 2022
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Sep 27, 2020
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
May 3, 2019
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Dec 18, 2018
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Sep 20, 2018
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Jul 25, 2016
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Apr 28, 2016
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
May 29, 2015
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Jul 11, 2014
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Aug 29, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Aug 19, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→
Feb 22, 2013
approval
KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
trastuzumab emtansine
→